Research News and Research

RSS

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

The corpus delicti is a plain flacon from among the possessions of Pharaoh Hatshepsut, who lived around 1450 B.C., which is on exhibit in the permanent collection of the Egyptian Museum of the University of Bonn. For three and a half millennia, the vessel may have held a deadly secret. This is what the Head of the collection, Michael H-veler-M-ller and Dr. Helmut Wiedenfeld from the university's Pharmacology Institute just discovered.

20 Aug 2011

Scientists report molecular structural basis for sex organ, head deformities

Scientists this month reported the molecular structural basis for severe head deformities and ambiguous sex organs in babies born with Antley-Bixler syndrome accompanied by an enzyme deficiency.

20 Aug 2011

Babies of mothers with higher pre-pregnancy BMI are fatter, finds study

Babies of mothers with a higher pre-pregnancy body mass index (BMI) are fatter and have more fat in their liver, a study published in September's issue of the journal Pediatric Research has found.

20 Aug 2011

Viewpoints: Tea party & Medicare; Minn. health exchange politics; fixing drug shortages

Unlike the Florida district court that earlier found ObamaCare unconstitutional, the 11th Circuit did not invalidate the entire law. But it likewise reaffirmed the fundamental constitutional rule that our federal government is one of enumerated powers with judicially enforceable limits.

20 Aug 2011

Gulf Coast Medical Center in Panama City joins UAB Cancer Care Network

Residents of Bay County, Fla., and surrounding communities will have access to the advanced care of the University of Alabama at Birmingham Cancer Care Network now that Gulf Coast Medical Center in Panama City has joined as its first Florida affiliate.

20 Aug 2011

NIH-supported project expands genetic research into clinical setting

Northwestern University Feinberg School of Medicine researchers have received a $762,000 grant from the National Institutes of Health (NIH) to tailor drug treatments to patients' genomic information.

20 Aug 2011

Researchers turn their attention to Chagas disease as developed countries see rise in infection rates

Chagas disease, a historically neglected tropical disease that the WHO estimates affects about 10 million people worldwide, is drawing increased attention as infection by the parasite spreads from Latin America to developed countries, such as Spain and the United States, Science reports.

20 Aug 2011

Wistar Institute, Graham Cancer Center enter research collaboration

Christiana Care Health System's Helen F. Graham Cancer Center and The Wistar Institute, an international leader in biomedical research, have entered into an historic partnership to collaborate on translational cancer research with the aim of bringing the latest discoveries in cancer research to cancer patients in the community.

20 Aug 2011

Combination of exercise and metformin less effective for people with diabetes

It's common enough for researchers to look at the impacts of prescribed drugs on the body. And if you're a diabetes researcher who believes that exercise has great benefits for those with type 2 diabetes, you're hoping your research will show that. But when Normand Boul- looked at the dual impacts of exercise and metformin - two of the most commonly-prescribed modalities for glucose control - on that very outcome, the hoped-for double whammy wasn't the result.

20 Aug 2011

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Seattle Genetics, Inc. today announced that the U.S. Food and Drug Administration has granted accelerated approval of ADCETRISTM for two indications: (1) the treatment of patients with Hodgkin lymphoma after failure of autologous stem cell transplant or after failure of at least two prior multi-agent chemotherapy regimens in patients who are not ASCT candidates, and (2) the treatment of patients with systemic anaplastic large cell lymphoma after failure of at least one prior multi-agent chemotherapy regimen.

20 Aug 2011

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

The authors "analyzed malpractice data from 1991 through 2005 for all physicians who were covered by a large professional liability insurer with a nationwide client base" and found that "by the age of 65 years, 75% of physicians in low-risk specialties had faced a malpractice claim, as compared with 99% of physicians in high-risk specialties." Most of those claims did not result in a pyament.

20 Aug 2011

Pros and cons of penis extender systems

For men, choosing the right penis extender to stimulate the growth of their penis can be confusing. With so many penis extenders on the market and very few resources highlighting the pros and cons of each system, consumers are as confused as ever as to which one will produce the best results.

20 Aug 2011

White House budget chief orders agencies to find savings — sets target 5% below current year spending levels

It's a microcosm of the budget battling that has consumed Congress all year: The Obama administration wants federal agencies to save money while Republicans push for additional savings to take a substantial bite out of the government's towering pile of IOUs. White House budget chief Jacob Lew has ordered agency heads to submit spending plans for the upcoming budget at least 5 percent below this year's levels. He also wants them to propose ways to trim a total of at least 10 percent of their spending.

20 Aug 2011

NIH approves BioTime's four GMP human embryonic stem cell lines

BioTime, Inc., a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that four human embryonic stem (hES) cell lines: ESI-035, ESI-049, ESI-051 and ESI-053, developed by a BioTime subsidiary have been approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry.

20 Aug 2011

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

The U.S. Food and Drug Administration today approved Adcetris to treat Hodgkin lymphoma and a rare lymphoma known as systemic anaplastic large cell lymphoma.

20 Aug 2011

News highlights: Calif. ruling limits medical damages; appeal filed in case challenging Ariz. Medicaid cuts

The state Supreme Court handed insurers and business groups a major legal victory -- and personal injury lawyers an equally big setback -- on Thursday by imposing limits on medical damages in one of the era's closest watched civil cases. The issue in the case, Howell v. Hamilton Meats & Provisions, was whether an injured party could collect the full medical care costs billed by doctors and hospitals, or the lesser amount that the medical providers accepted from an insurance company.

20 Aug 2011

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

Medicinal Genomics, a private company headquartered in Marblehead, Mass., USA and the Netherlands, announced today that it has sequenced the entire genomes of Cannabis sativa and Cannabis indica, representing two strains of the therapeutic plant.

19 Aug 2011

First 5 LA awards Valley Presbyterian Hospital $500,000 to improve breastfeeding rates

First 5 LA announced today that it is awarding a grant of nearly $500,000 to Valley Presbyterian Hospital to improve the nutrition and health of the hospital's youngest patients by developing and maintaining policies and procedures to encourage increased breastfeeding among mothers of newborns.

19 Aug 2011

Cost is only one barrier to getting timely medical care, finds study

Cost is only one barrier to getting timely medical care, a new study finds. Just getting to the doctor, making appointments and taking time off from work or other responsibilities are also major hindrances for some people to getting the medical care they need.

19 Aug 2011

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.

19 Aug 2011

Research News and Research

Scientists shed light on the dark secret of Queen Hatshepsut's deadly medication

Scientists report molecular structural basis for sex organ, head deformities

Babies of mothers with higher pre-pregnancy BMI are fatter, finds study

Viewpoints: Tea party & Medicare; Minn. health exchange politics; fixing drug shortages

Gulf Coast Medical Center in Panama City joins UAB Cancer Care Network

NIH-supported project expands genetic research into clinical setting

Researchers turn their attention to Chagas disease as developed countries see rise in infection rates

Wistar Institute, Graham Cancer Center enter research collaboration

Combination of exercise and metformin less effective for people with diabetes

FDA approves Seattle Genetics ADCETRIS drug to treat Hodgkin lymphoma, ALCL

Research roundup: Majority of Docs face malpractice claims; colonoscopies in older adults; 'overwhelming' Medicare advantage choices

Pros and cons of penis extender systems

White House budget chief orders agencies to find savings — sets target 5% below current year spending levels

NIH approves BioTime's four GMP human embryonic stem cell lines

Seattle Genetics receives FDA approval for Adcetris to treat Hodgkin lymphoma, ALCL

News highlights: Calif. ruling limits medical damages; appeal filed in case challenging Ariz. Medicaid cuts

Medicinal Genomics sequences entire genomes of two therapeutic Cannabis strains

First 5 LA awards Valley Presbyterian Hospital $500,000 to improve breastfeeding rates

Cost is only one barrier to getting timely medical care, finds study

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest Life Science News